Lisinopril Tablets

Protecting your heart and blood vessels over the long term begins with consistent management of conditions such as high blood pressure and heart failure. Lisinopril tablets are a well-established prescription-only ACE inhibitor used in adults across several cardiovascular indications. Lisinopril is one of the most widely prescribed antihypertensive medicines in the UK and features on the NHS core formulary for blood pressure control and heart failure management. A prescription can only be issued following a clinical consultation.

Lisinopril tablets are an oral prescription medicine containing lisinopril as the active ingredient. Unlike fosinopril and enalapril, lisinopril is an active drug that does not require conversion to an active form in the body, it acts directly as an ACE inhibitor without needing to be metabolised first.

Lisinopril is licensed in the UK for three indications. First, it is used for the treatment of hypertension (high blood pressure). Second, it is used as an adjunctive treatment in adults with symptomatic heart failure alongside conventional therapy such as diuretics and, where appropriate, digoxin. Third, it is used for the short term treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction (heart attack) to reduce the risk of subsequent heart failure and to improve survival. This third indication is typically managed in hospital and would not be initiated through an online prescribing service.

Lisinopril is available as a generic medicine from multiple manufacturers. Four strengths are available through this service: 2.5 mg, 5 mg, 10 mg, and 20 mg. The large range of available strengths supports careful dose titration across all three licensed indications.

Lisinopril works by inhibiting the angiotensin-converting enzyme (ACE), a key enzyme in the renin-angiotensin system. This system plays a central role in blood pressure regulation and fluid balance.

The Renin-Angiotensin System

The renin-angiotensin system regulates blood pressure through a hormonal cascade. The kidneys release renin in response to low blood pressure or low sodium. Renin triggers the conversion of angiotensinogen to angiotensin I, which is then converted by ACE to angiotensin II. Angiotensin II causes blood vessels to narrow and stimulates the release of aldosterone, which causes the kidneys to retain sodium and water. Both effects raise blood pressure.

ACE Inhibition

Lisinopril blocks the ACE enzyme directly. By preventing the conversion of angiotensin I to angiotensin II, lisinopril stops the downstream vasoconstriction and sodium retention that angiotensin II would cause. Blood vessels remain relaxed and widened, circulating fluid volume decreases modestly, and blood pressure falls as a result.

In heart failure, this reduction in vascular resistance and circulating volume reduces the workload on the heart. The heart can pump more efficiently against lower resistance, which helps to improve symptoms and cardiac function. This cardiovascular protective effect is why ACE inhibitors are a cornerstone of heart failure therapy and why lisinopril holds its multiple licensed indications.

Unlike some other ACE inhibitors, lisinopril is not a prodrug. It is absorbed directly from the gut and exerts its effect without requiring hepatic conversion. It is also eliminated primarily by the kidneys, which is a consideration in patients with impaired kidney function.

Always take lisinopril exactly as your prescriber instructs. The information below summarises key points from the current UK SmPC. Read the Patient Information Leaflet supplied with your medicine before starting treatment.

• Take lisinopril once daily, at approximately the same time each day.
• Lisinopril can be taken with or without food.
• Swallow the tablet whole with a glass of water.
• If you miss a dose, take it as soon as you remember on the same day. If you only remember the following day, skip the missed dose and continue with your normal schedule. Do not take two doses on the same day.
• Do not stop taking lisinopril without speaking to your prescriber first. High blood pressure and heart failure both require ongoing management, and stopping suddenly can allow these conditions to worsen.
• Your prescriber will typically start you at a lower dose and increase it gradually over several weeks, monitoring your blood pressure, kidney function, and potassium levels. This gradual titration approach is standard for ACE inhibitors and is particularly important in heart failure and in patients taking diuretics. Attend all follow up appointments so that your response to treatment can be assessed safely.

Lisinopril is available in four strengths. The appropriate dose depends on the indication being treated and your individual clinical response. All dosing decisions are made by your prescriber.

Lisinopril 2.5 mg Tablets

The 2.5 mg tablet is the lowest available strength. It is used as the starting dose in patients where extra caution is required at initiation, particularly in heart failure patients, those with very low blood pressure, patients with significant kidney impairment, or those taking diuretics who may be at risk of a first dose blood pressure drop. Starting at 2.5 mg allows the prescriber to assess tolerability before any dose increase.

Lisinopril 5 mg Tablets

The 5 mg tablet is a common starting dose for hypertension in adults who do not have the clinical risk factors that would require the 2.5 mg starting dose. For heart failure, 5 mg may also be used as an early maintenance dose following careful dose titration from 2.5 mg.

Lisinopril 10 mg Tablets

The 10 mg tablet is a standard maintenance dose for hypertension and is within the usual therapeutic range for heart failure. Many patients will be established on 10 mg once daily for long term blood pressure control. If blood pressure is not adequately controlled at 10 mg, the prescriber may consider increasing to 20 mg.

Lisinopril 20 mg Tablets

The 20 mg tablet is the standard maximum dose for hypertension, though some patients may be maintained on doses up to 40 mg under specialist guidance. In heart failure, target doses of up to 35 mg once daily are used in some clinical protocols, though the SmPC licensed maximum for hypertension is 40 mg. All dose escalation decisions rest with the prescriber. Do not change your dose without medical advice.

Like all medicines, lisinopril can cause side effects, although not everyone experiences them. The information below is based on the current UK SmPC. Refer to the Patient Information Leaflet for the full list of side effects.

Common Side Effects (may affect up to 1 in 10 people)

• Dry, persistent cough. This is the most frequently reported side effect of lisinopril and other ACE inhibitors. It results from the accumulation of bradykinin caused by ACE inhibition and can occur at any time during treatment. If the cough is troublesome, speak to your prescriber about alternatives.
• Dizziness or lightheadedness, particularly on standing. This is more likely at the start of treatment or after a dose increase.
• Headache
• Fatigue

Uncommon Side Effects (may affect up to 1 in 100 people)

• Nausea, vomiting, or diarrhoea
• Raised blood potassium (hyperkalaemia), which may cause muscle weakness or palpitations
• Changes in kidney function, particularly in patients with pre existing kidney disease or renovascular disease
• Skin rash

Serious Side Effects: Seek Urgent Medical Attention

Go to your nearest accident and emergency department or call 999 immediately if you experience:

• Angioedema: sudden swelling of the face, lips, tongue, or throat. This is a rare but potentially life threatening reaction associated with all ACE inhibitors, including lisinopril. It can occur at any point during treatment. Swelling of the throat can obstruct breathing and requires emergency medical attention immediately.
• Signs of severely raised potassium such as muscle weakness, an irregular heartbeat, or confusion
• Signs of a significant reduction in kidney function such as a marked fall in urine output

Report any suspected side effect to your prescriber, pharmacist, or via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Lisinopril Tablets May Be Suitable If You:

• Are an adult with a confirmed diagnosis of hypertension
• Have symptomatic heart failure and are being treated with conventional therapy including diuretics
• Are already prescribed lisinopril and require a repeat prescription through an online prescribing service

Lisinopril Tablets Are Not Suitable If You:

• Are pregnant or planning to become pregnant. Lisinopril is contraindicated in pregnancy. ACE inhibitors can cause serious harm to the developing baby, particularly in the second and third trimesters, including kidney damage and foetal death. Contact your prescriber immediately if you become pregnant while taking lisinopril.
• Are breastfeeding
• Have a history of angioedema related to previous ACE inhibitor treatment, or hereditary or idiopathic angioedema
• Have severe kidney impairment or are on dialysis
• Are taking aliskiren containing medicines and have diabetes or moderate to severe kidney impairment
• Have a known allergy or hypersensitivity to lisinopril, any other ACE inhibitor, or any excipient listed in the SmPC
• Are under 18 years of age

Tell your prescriber about all medicines you take, including over the counter products and herbal supplements. The following interactions are of particular clinical importance:

• Potassium supplements, potassium-sparing diuretics (such as spironolactone or amiloride), and potassium-containing salt substitutes: these can raise blood potassium to dangerous levels when combined with lisinopril.
• NSAIDs such as ibuprofen: regular use can reduce the blood pressure lowering effect of lisinopril and may increase the risk of kidney problems, particularly in older patients or those with pre existing renal impairment.
• Lithium: ACE inhibitors can increase lithium blood levels, raising the risk of lithium toxicity. Close monitoring is required.
• Diuretics: combining lisinopril with a diuretic can cause a significant fall in blood pressure, particularly with the first dose. Your prescriber will manage this carefully.
• Aliskiren: contraindicated in combination with lisinopril in patients with diabetes or significant kidney impairment.
• Antidiabetic medicines including insulin: ACE inhibitors may enhance the blood glucose lowering effect of antidiabetic medicines. Patients with diabetes should be aware of this and monitor blood glucose as advised.

Your prescriber will carry out a full clinical assessment, including a review of your current medicines, before any prescription is considered.

Lisinopril is a Prescription Only Medicine. The clinical consultation is the essential first step. A prescription will only be issued if a registered prescriber concludes, based on their individual assessment of your circumstances, that lisinopril is clinically appropriate for you.

During your online consultation with Pharmacy Planet, a registered prescriber will review the information you provide. This includes your diagnosis, blood pressure history, whether you have heart failure, your current medicines, kidney function where known, and any other relevant medical history. Based on this assessment, the prescriber will decide whether lisinopril is appropriate, which strength is suitable, and whether the online service is appropriate for your situation.

If you are under the care of your GP, a cardiologist, or a heart failure specialist, please keep them informed of all medicines prescribed through online services. Coordinated care gives you the safest outcome for your BP regulation and cardiovascular therapy.

• Store below 25°C.
• Store in the original packaging to protect from moisture and light.
• Keep out of the sight and reach of children.
• Do not use after the expiry date printed on the packaging.
• Do not dispose of medicines via household waste or wastewater. Return unused or out of date tablets to your pharmacist for safe disposal.
• Full storage instructions are provided in the Patient Information Leaflet supplied with your medicine.

The table below compares commonly prescribed ACE inhibitor tablets and capsules available at Pharmacy Planet. All are prescription-only medicines that act on the renin-angiotensin system to lower blood pressure.

Important: This comparison is for general information only and does not replace medical advice. A prescriber will decide which treatment is suitable for you following an online consultation.

Pharmacy Planet is a GPhC-registered online pharmacy providing access to prescription medicines through a clinically led consultation process. Our registered prescribers and pharmacists are committed to patient safety, clinical accuracy, and responsible prescribing.

We follow GPhC standards, MHRA guidance, and ASA advertising regulations in all aspects of our service. Every prescription is reviewed and dispensed by qualified healthcare professionals. We aim to provide the clear, factual information you need to understand your antihypertensive medication and make well-informed decisions about your heart health and cardiovascular therapy.

If you have questions about lisinopril, blood pressure control, or any other aspect of your treatment, our pharmacy team is available to help. We are committed to transparent, patient centred care.

References

1. Electronic Medicines Compendium (eMC). Lisinopril 2.5 mg, 5 mg, 10 mg and 20 mg tablets — Summary of Product Characteristics. https://www.medicines.org.uk/emc. Accessed May 2026.
2. National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. NICE guideline NG136. https://www.nice.org.uk/guidance/ng136. Accessed May 2026.
3. National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management. NICE guideline NG106. https://www.nice.org.uk/guidance/ng106. Accessed May 2026.
4. NHS. Lisinopril. https://www.nhs.uk/medicines/lisinopril. Accessed May 2026.
5. Joint Formulary Committee. British National Formulary (BNF). Lisinopril. BMJ Group and Pharmaceutical Press. https://bnf.nice.org.uk. Accessed May 2026.
6. Medicines and Healthcare products Regulatory Agency (MHRA). Yellow Card — report a side effect. https://yellowcard.mhra.gov.uk. Accessed May 2026.